Ligand validation:7OVO

QEI: 2-amino-5-({[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino}methyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one

QEI is a Ligand Of Interest in 7OVO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7OVO_QEI_C_501	41%	6%	0.189	0.903	1.35	3.63	2	4	0	0	100%	0.826
7OWZ_QEI_C_502	41%	43%	0.192	0.908	1.05	1.14	1	1	0	0	100%	0.852
8DL3_QEI_A_401	88%	27%	0.091	0.966	1.68	1.27	3	2	1	0	100%	1
4HVX_QEI_A_405	51%	12%	0.096	0.913	2.06	2	2	2	0	0	65%	0.611
4HQV_QEI_A_406	26%	12%	0.128	0.83	2.26	1.87	3	2	0	0	65%	0.5265
3BLO_QEI_A_600	11%	8%	0.166	0.681	1.43	3.12	3	7	1	0	100%	0.45

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.